Company Profile

Gal Tech Wound Therapies (AKA: Chrysalis BioTechnology Inc)
Profile last edited on: 12/28/06      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
----
First Award
1995
Latest Award
2002
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5020 Cedar Creek Drive
Dickinson, TX 77539
   (409) 772-3210
   N/A
   N/A
Location: Single
Congr. District: 14
County: Galveston

Public Profile

In August of 2004 OrthoLogic acquired Gal Tech Wound Therapies, formerly known as Chrysalis BioTechnology Inc

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2002 1 NIH $100,000
Project Title: Revascularization of Ischemic Heart Tissue by TP508
2001 2 NIH $849,928
Project Title: Accelerated Bone Repair by Thrombin-Derived Peptide
2000 1 NIH $99,999
Project Title: Inhibition of Vascular Restenosis by the TP508 Peptide
1999 2 NIH $850,000
Project Title: Healing Of Chronic Ulcers Using Thrombin Peptides
1999 1 NIH $100,001
Project Title: Cartilage Repair Induced by Thrombin Peptide TP508

Key People / Management

  Roger S Crowther

  Andrea M Norfleet

  Janet Stiernberg

Company News

There are no news available.